About

Ellen Relkin is a seasoned personal injury attorney based in New York City, specializing in medical device and pharmaceutical product liability, as well as toxic tort cases. With extensive experience in representing plaintiffs harmed by defective medical products, she has recently concentrated her efforts on cases involving failed metal-on-metal hip implants. Ms. Relkin holds prestigious leadership roles, serving as Co-Lead Counsel in the In Re: DePuy ASR Multi-District Litigation and as Lead and Liaison Counsel in the New Jersey In Re: Stryker Rejuvenate & ABG II Modular Hip Implant Litigation. She is also a member of the Plaintiff Steering Committee for the In Re: Biomet Hip Implant Litigation. A notable achievement in her career includes being part of the trial team that secured a landmark $13.5 million verdict against Merck in a failure-to-warn case related to Vioxx, which she successfully defended on appeal. Certified as a Civil Trial Attorney by the New Jersey Supreme Court, Ms. Relkin is an elected member of the American Law Institute and serves on the Board of Governors for the New Jersey Trial Lawyers Association. Her professional affiliations extend to the American Association for Justice, where she has chaired the Toxic, Environmental, and Pharmaceutical Torts section, and the American Bar Association, where she co-chaired the Pharmaceutical and Medical Device Subcommittee. Ms. Relkin is also a frequent lecturer at national legal education programs and has published numerous articles in respected legal journals. Her litigation practice encompasses a variety of cases, including those involving Yaz and Yasmin birth control products, as well as women injured by Power Morcellators during laparoscopic procedures.

Related Legal Services

Other Personal Injury Attorneys in New York City, NY

More Attorneys at Weitz & Luxenberg, P.C.